|
|
Article: ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System.
- Article from:
- PR Newswire
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
EDINA, Minn., Nov. 5 /PRNewswire/ -- ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
The new meter and strip platform, which ARKRAY will make available for distribution in early December, is expected to be a significant complement to the existing GLUCOCARD line of products, and will be ideal for the home medical equipment (HME), durable medical equipment (DME), mail order and managed care markets.
"We're very excited about the latest addition to our GLUCOCARD ...
Related newspaper, magazine, and journal articles:
|
|
Article: ARKRAY, Inc. Offers MyCareTeamTM Disease Management ...
Diabetes Week;
August 17, 2009 ;
700+ words
...ARKRAY, Inc., the world's fifth largest manufacturer ... for patients and health care providers, ARKRAY has an obligation to extend every advantage ... said Jonathan Chapman, president of ARKRAY, USA. "This agreement with MyCareTeam ...
|
|